{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:09:14Z","timestamp":1792786154496,"version":"4.5.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"30","license":[{"start":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T00:00:00Z","timestamp":1784851200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"This work is supported by Kunming Medical University Joint Special Project","award":["202401AY070001-090"],"award-info":[{"award-number":["202401AY070001-090"]}],"id":[{"id":"https:\/\/ror.org\/038c3w259","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Yunnan Provincial Health and Health Commission Provincial Clinical Medical Center Scientific Research Project","award":["2024YNLCYXZX0525"],"award-info":[{"award-number":["2024YNLCYXZX0525"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study quantified and compared the 2006 to 2021 burden (incidence, mortality, and disability-adjusted life years [DALYs]) of alcohol- and nonalcoholic fatty liver disease (NAFLD)\/nonalcoholic steatohepatitis (NASH)-related cirrhosis and hepatocellular carcinoma (HCC) across China, Japan, South Korea, North Korea (Democratic People\u2019s Republic of Korea [DPRK]), and Mongolia to inform targeted prevention and policy priorities. Utilizing Global Burden of Disease (GBD) 2021 data, we analyzed the epidemiology of alcohol-related liver disease and NAFLD\/NASH leading to cirrhosis and HCC. Using data from the GBD 2021 study, we calculated age-standardized incidence rates, age-standardized mortality rates, and age-standardized DALY rates, and assessed temporal trends using estimated annual percentage changes and segmented regression analysis. In 2021, China recorded the highest absolute all-age incidence, mortality, and DALYs for alcoholic cirrhosis, NASH-related HCC, and NAFLD-related cirrhosis. However, in terms of age-standardized incidence rates, age-standardized mortality rates, and age-standardized DALY rates, Mongolia bears the heaviest overall disease burden. Conversely, the lowest age-standardized burdens varied: alcohol-related HCC was lowest in DPRK, alcoholic cirrhosis in China, NASH-related HCC in Japan, and NAFLD in South Korea and Japan. From 2006 to 2021, alcohol-related HCC metrics declined in Japan, South Korea, and DPRK but rose modestly in China and Mongolia. Alcoholic cirrhosis declined in all 5 countries, most notably in Japan, South Korea, and Mongolia. NASH-related HCC generally decreased in Japan, South Korea, and DPRK, while increasing slowly in China and remaining stable in Mongolia. Notably, while NAFLD prevalence and incidence rose across all 5 nations, associated DALYs declined, suggesting improved clinical management despite intensifying upstream metabolic risks. East Asian countries exhibit a heterogeneous yet convergent transition where alcohol- and metabolism-related liver diseases are displacing viral etiologies. While alcoholic cirrhosis incidence is declining regionally, the rising burden of alcohol-related HCC in China and Mongolia, alongside increasing NAFLD\/NASH incidence, necessitates a policy shift. Priorities should include comprehensive alcohol control, metabolic risk reduction, and targeted fibrosis\/HCC screening in high-risk populations. Although GBD data are subject to inherent biases, they provide actionable guidance for regional health strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049944","type":"journal-article","created":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T19:01:52Z","timestamp":1784919712000},"page":"e49944","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Burden and trends of alcohol- and NAFLD\/NASH-related liver disease in 5 East Asian countries: A GBD 2021 analysis"],"prefix":"10.1097","volume":"105","author":[{"given":"Bing","family":"Liang","sequence":"first","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China"},{"name":"Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjin","family":"Shi","sequence":"additional","affiliation":[{"name":"Department of Urology, the Second Affiliated Hospital of Kunming Medical University, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Tie","sequence":"additional","affiliation":[{"name":"Kunming Medical University, Kunming, China"},{"name":"Department of Integrative Medicine, The Third Affiliated Hospital of Kunming Medical University\/Yunnan Cancer Hospital\/Yunnan Hospital of Peking University Cancer Hospital, Kunming, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingbin","family":"Zeng","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-0410-751X","authenticated-orcid":false,"given":"Kui","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Hepatopancreatobiliary Surgery, The Second Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261001","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.jhep.2023.03.017","article-title":"Global burden of liver disease: 2023 update.","volume":"79","author":"Devarbhavi","year":"2023","journal-title":"J Hepatol"},{"key":"R2-20261001","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jhep.2018.09.014","article-title":"Burden of liver diseases in the world.","volume":"70","author":"Asrani","year":"2019","journal-title":"J Hepatol"},{"key":"R3-20261001","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review.","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"R4-20261001","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.1016\/S2214-109X(22)00035-3","article-title":"Clearing our heads over alcohol.","volume":"10","year":"2022","journal-title":"Lancet Glob Health"},{"key":"R5-20261001","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis.","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R6-20261001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S2468-1253(19)30349-8","article-title":"The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"5","author":"Sepanlou","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R7-20261001","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016\u20132030.","volume":"69","author":"Estes","year":"2018","journal-title":"J Hepatol"},{"key":"R8-20261001","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer.","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"R9-20261001","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies.","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"R10-20261001","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/hep.29466","article-title":"Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease.","volume":"67","author":"Estes","year":"2018","journal-title":"Hepatology"},{"key":"R11-20261001","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jhep.2023.03.040","article-title":"Global incidence of non-alcoholic fatty liver disease: a systematic review and meta-analysis of 63 studies and 1,201,807 persons.","volume":"79","author":"Le","year":"2023","journal-title":"J Hepatol"},{"key":"R12-20261001","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological features of NAFLD from 1999 to 2018 in China.","volume":"71","author":"Zhou","year":"2020","journal-title":"Hepatology"},{"key":"R13-20261001","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1038\/s41392-024-02072-z","article-title":"Liver diseases: epidemiology, causes, trends and predictions.","volume":"10","author":"Gan","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"R14-20261001","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2468-1253(19)30039-1","article-title":"Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999\u20132019: a systematic review and meta-analysis.","volume":"4","author":"Li","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R15-20261001","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrgastro.2017.109","article-title":"Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention.","volume":"15","author":"Younossi","year":"2018","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R16-20261001","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-021-03362-0","article-title":"NASH limits anti-tumour surveillance in immunotherapy-treated HCC.","volume":"592","author":"Pfister","year":"2021","journal-title":"Nature"},{"key":"R17-20261001","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.cgh.2015.07.019","article-title":"Hepatocellular carcinoma in the absence of cirrhosis in United States veterans is associated with nonalcoholic fatty liver disease.","volume":"14","author":"Mittal","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R18-20261001","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1186\/s12889-024-17948-6","article-title":"Global burden of liver cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2019.","volume":"24","author":"Wu","year":"2024","journal-title":"BMC Public Health"},{"key":"R19-20261001","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1016\/S0140-6736(18)32744-2","article-title":"Global alcohol exposure between 1990 and 2017 and forecasts until 2030: a modelling study.","volume":"393","author":"Manthey","year":"2019","journal-title":"Lancet"},{"key":"R20-20261001","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-2667(24)00250-0","article-title":"Diabetes in China part 1: epidemiology and risk factors.","volume":"9","author":"Xu","year":"2024","journal-title":"Lancet Public Health"},{"key":"R21-20261001","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S2213-8587(25)00131-7","article-title":"China launches National Obesity Campaign.","volume":"13","author":"Sun","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"R23-20261001","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1186\/s12876-025-04264-5","article-title":"Global burden of cirrhosis and other chronic liver diseases caused by specific etiologies from 1990 to 2021.","volume":"25","author":"Zhang","year":"2025","journal-title":"BMC Gastroenterol"},{"key":"R24-20261001","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11113-024-09903-5","article-title":"The future process of Japan\u2019s population aging: a cluster analysis using small area population projection data.","volume":"43","author":"Inoue","year":"2024","journal-title":"Population Res Pol Rev"},{"key":"R25-20261001","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1016\/S0140-6736(18)31310-2","article-title":"Alcohol use and burden for 195 countries and territories, 1990\u20132016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"392","author":"Griswold","year":"2018","journal-title":"Lancet"},{"key":"R26-20261001","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/s41575-024-00967-4","article-title":"Liver diseases and hepatocellular carcinoma in the Asia-Pacific region: burden, trends, challenges and future directions.","volume":"21","author":"Mak","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R27-20261001","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis.","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"R28-20261001","doi-asserted-by":"crossref","first-page":"2809","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis.","volume":"20","author":"Le","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R29-20261001","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease.","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"R30-20261001","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/s41575-021-00523-4","article-title":"Advancing the global public health agenda for NAFLD: a consensus statement.","volume":"19","author":"Lazarus","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R31-20261001","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41575-023-00798-9","article-title":"Measuring NAFLD models of care.","volume":"20","author":"Allen","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"R32-20261001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/liv.13682","article-title":"Liver diseases: a major, neglected global public health problem requiring urgent actions and large\u2010scale screening.","volume":"38","author":"Marcellin","year":"2018","journal-title":"Liver Int"},{"key":"R33-20261001","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jhep.2021.10.025","article-title":"The global NAFLD policy review and preparedness index: are countries ready to address this silent public health challenge?","volume":"76","author":"Lazarus","year":"2022","journal-title":"J Hepatol"},{"key":"R34-20261001","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/j.jhep.2021.09.024","article-title":"Asian perspective on NAFLD-associated HCC.","volume":"76","author":"Yip","year":"2022","journal-title":"J Hepatol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049944","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T18:01:44Z","timestamp":1790877704000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000049944"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,24]]},"references-count":33,"journal-issue":{"issue":"30","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049944","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,24]]},"assertion":[{"value":"2026-02-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-30","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}